MedTrace Logo

Sentinel Lymph Node Biopsy With Hybrid Technique in Breast Cancer

NCT04274946 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2020-02-19

No results posted yet for this study

Summary

Sentinel lymph node (SLN) biopsy is the gold standard method to stage axilla in breast cancer. The aim of the study is to compare the efficiency of various methods to identify SLN is breast cancer patients.

Conditions

Interventions

PROCEDURE

Sentinel lymph node biopsy

Sentinel lymph node biopsy(SLNB) procedure with different mapping methods using combination of radioactive colloid, patent blue, indocyanine green associated with intraoperative ultrasound.

Sponsors & Collaborators

  • Bulent Ecevit University

    lead OTHER

Principal Investigators

  • Güldeniz Karadeniz Cakmak, MD · Bülent Ecevit University Department of Surgery

  • Rabiye Uslu Erdemir, MD · Bülent Ecevit University Department of Nucleer Medicine

  • Hakan Bakkal, MD · Bülent Ecevit University Department of Radiation Oncology

  • Hüseyin Engin, MD · Bülent Ecevit University Department of Clinical Oncology

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-01-01
Completion
2025-01-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04274946 on ClinicalTrials.gov